|
|
|
14.07.26 - 08:01
|
Roche Unveils Cobas Hepatitis D Virus Test (AFX)
|
|
|
SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY, RO.SW, ROG.SW) announced that it introduced the cobas HDV test for use on the cobas 5800/6800/8800 systems, a diagnostic tool for the detection and qu......
|
|
|
|
|
|
|
13.07.26 - 08:06
|
Sofinnova Partners Appoints David Evans as Partner (Business Wire)
|
|
|
Sofinnova strengthens its growth strategy with a high-caliber London-based Partner:
Physician-scientist combining frontline clinical experience, health financing and policy expertise, and a proven track record in venture capital
Over 20 years in drug development at Bristol Myers Squibb, Eli Lilly, and the Roche Venture Fund as well as in healthcare policy and financing
PARIS--(BUSINESS WIRE)--Sofinnova Partners ("Sofinnova"), a leading European venture capital firm in life sciences, based in Paris, London, and Milan, announced the appointment of David Evans as Partner. A physician-scientist with deep pharma and drug development expertise, Evans joins from the Roche Venture Fund, where he most recently served as Senior Investment Director. His career spans frontline patient care as a doctor in Australia and with Médecins Sans Frontières, health policy and financing at the World Bank, and roles across the pharmaceutical industry in health economics & outcomes research and drug development before...
|
|
|
|
|
10.07.26 - 11:48
|
ABB Robotics collaborates with Roche to bring physical AI to laboratories (Cision)
|
|
|
Zurich, Switzerland, July 8, 2026
ABB Robotics collaborates with Roche to bring physical AI to laboratories
· Agreement lays the foundation for a new era of digitally connected labs enabled by intelligent robotics to provide significant efficiencies in laboratory workflows
· First applications under collaboration will support pathology slide handling and autonomous connectivity in Core Lab intralogistics
· Range of ABB Robotics' technologies deployed, including autonomous mobile manipulation and fixed articulating robots
ABB Robotics has announced a global collaboration...
|
|
|
|
|
|
|
|
|
09.07.26 - 07:03
|
Roche receives CE Mark for blood test to identify tuberculosis infection (GlobeNewswire EN)
|
|
|
Basel, 9 July 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that its Elecsys IGRA TB test has received the CE Mark, introducing a new blood testing solution for identifying tuberculosis infection (TBI, also known as latent TB) in routine laboratory settings. The new solution enables fast, simple, and efficient diagnosis, and can provide results in under 24 hours. The Interferon Gamma Release Assay (IGRA) itself takes just 19 minutes per patient to process, which is approximately half the time of currently used methods. Laboratories now have an option for IGRA testing, with faster turnaround and scalable throughput on Roche's systems....
|
|
|
|
|
|
|
|
|
07.07.26 - 07:03
|
Roche presents new data in Alzheimer′s disease from across its integrated pharmaceutical and diagnostics portfolio at AAIC (GlobeNewswire EN)
|
|
|
Basel, 7 July 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it will present new data from its Alzheimer's disease portfolio at the Alzheimer's Association International Conference® 2026 (AAIC®) in London on 12-15 July. These data demonstrate how Roche is advancing the development of next-generation medicines and diagnostic tests, driven by a mission to slow, stop or even prevent the progression of Alzheimer's disease. In total, there are 18 oral and poster presentations. Highlights include five oral presentations as part of a trontinemab Featured Research Session, an oral Perspectives Session on neuroimmune targets such as NLRP3 for neurodegenerative diseases, and presentations on the use of Roche's Elecsys® pTau217 and pTau181 blood tests to support Alzheimer's disease diagnosis....
|
|
|
|
|
|
|
|
|
|
|
|
|
|